机构:[1]State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University and Collaborative Innovation Center of Biotherapy, Chengdu 610041, China四川大学华西医院[2]Department of Chemistry and Institute for Biophysical Dynamics Howard Hughes Medical Institute, The University of Chicago, Chicago, IL 60637, USA[3]College of Life Sciences, Sichuan University, Chengdu 610041, China[4]Department of Thoracic Surgery, West China Hospital, Sichuan University, Chengdu 610041, China四川大学华西医院
MicroRNA (miRNA) dysregulation is associated with the tumorigenesis and development of numerous human cancers. The defect in miRNA biogenesis is the main cause of miRNA dysregulation. We previously demonstrated that ERK-induced phosphorylation of XPO5 followed by peptidyl-prolyl cis/trans isomerase Pin1-mediated isomerization downregulates miRNA expression and contributes to hepatocellular carcinoma (HCC) development. However, how Pin1 precisely regulates miRNA biogenesis in HCC remains elusive. Here we reveal that Pin1 has a pivotal role in the miRNA maturation process by modulating phosphorylated Serine-Proline (pS-P) motif of XPO5 in a phosphorylation-dependent manner. By recognizing and binding to XPO5 via its WW domain, Pin1 catalyzes the conformation change of XPO5 and diminishes XPO5 ability to export pre-miRNAs from the nucleus to the cytoplasm, resulting in the reduced mature miRNA levels and promoted HCC development. Furthermore, downregulation of Pin1 by shRNA restores XPO5-dependent pre-miRNA export and effective biogenesis of mature miRNAs, leading to both in vitro and in vivo HCC inhibition. Therefore, our research discloses a new posttranscriptional regulatory mechanism of miRNA biosynthesis and provides the experimental basis for a novel HCC therapy by targeting Pin1.
基金:
This work was supported by National Key R&D
Program of China (2017YFA0504304 and 2016YFA0502204 to Y.P.),
National Natural Science Foundation of China (81772960 and
81572739 to Y.P.), China Postdoctoral Science Foundation
(2017M612976 to W.P.).
语种:
外文
PubmedID:
中科院(CAS)分区:
出版当年[2018]版:
大类|1 区生物
小类|2 区生化与分子生物学2 区细胞生物学
最新[2023]版:
大类|1 区生物学
小类|1 区生化与分子生物学2 区细胞生物学
第一作者:
第一作者机构:[1]State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University and Collaborative Innovation Center of Biotherapy, Chengdu 610041, China
共同第一作者:
通讯作者:
通讯机构:[1]State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University and Collaborative Innovation Center of Biotherapy, Chengdu 610041, China[4]Department of Thoracic Surgery, West China Hospital, Sichuan University, Chengdu 610041, China
推荐引用方式(GB/T 7714):
Li Jiao,Pu Wenchen,Sun Hui-Lung,et al.Pin1 impairs microRNA biogenesis by mediating conformation change of XPO5 in hepatocellular carcinoma.[J].Cell death and differentiation.2018,25(9):1612-1624.doi:10.1038/s41418-018-0065-z.
APA:
Li Jiao,Pu Wenchen,Sun Hui-Lung,Zhou Jian-Kang,Fan Xin...&Peng Yong.(2018).Pin1 impairs microRNA biogenesis by mediating conformation change of XPO5 in hepatocellular carcinoma..Cell death and differentiation,25,(9)
MLA:
Li Jiao,et al."Pin1 impairs microRNA biogenesis by mediating conformation change of XPO5 in hepatocellular carcinoma.".Cell death and differentiation 25..9(2018):1612-1624